
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Targeted nanomedicines remodeling immunosuppressive tumor microenvironment for enhanced cancer immunotherapy
Yanyan Xu, Jingyuan Xiong, Xiyang Sun, et al.
Acta Pharmaceutica Sinica B (2022) Vol. 12, Iss. 12, pp. 4327-4347
Open Access | Times Cited: 123
Yanyan Xu, Jingyuan Xiong, Xiyang Sun, et al.
Acta Pharmaceutica Sinica B (2022) Vol. 12, Iss. 12, pp. 4327-4347
Open Access | Times Cited: 123
Showing 1-25 of 123 citing articles:
Current research trends of nanomedicines
Qiuyue Liu, Jiahui Zou, Zhongjian Chen, et al.
Acta Pharmaceutica Sinica B (2023) Vol. 13, Iss. 11, pp. 4391-4416
Open Access | Times Cited: 78
Qiuyue Liu, Jiahui Zou, Zhongjian Chen, et al.
Acta Pharmaceutica Sinica B (2023) Vol. 13, Iss. 11, pp. 4391-4416
Open Access | Times Cited: 78
Current advance of nanotechnology in diagnosis and treatment for malignant tumors
Bilan Wang, Shiqi Hu, Yan Teng, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 76
Bilan Wang, Shiqi Hu, Yan Teng, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 76
Reprogramming the immunosuppressive tumor microenvironment through nanomedicine: an immunometabolism perspective
Jieyu Liu, Yinan Bai, Yinggang Li, et al.
EBioMedicine (2024) Vol. 107, pp. 105301-105301
Open Access | Times Cited: 73
Jieyu Liu, Yinan Bai, Yinggang Li, et al.
EBioMedicine (2024) Vol. 107, pp. 105301-105301
Open Access | Times Cited: 73
Nano-enhanced immunotherapy: Targeting the immunosuppressive tumor microenvironment
Yuzhi Jin, Yangyue Huang, Hui Ren, et al.
Biomaterials (2024) Vol. 305, pp. 122463-122463
Closed Access | Times Cited: 42
Yuzhi Jin, Yangyue Huang, Hui Ren, et al.
Biomaterials (2024) Vol. 305, pp. 122463-122463
Closed Access | Times Cited: 42
Branched glycopolymer prodrug-derived nanoassembly combined with a STING agonist activates an immuno-supportive status to boost anti-PD-L1 antibody therapy
Zhilin Li, Qianfeng Zhang, Zhiqian Li, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 5, pp. 2194-2209
Open Access | Times Cited: 28
Zhilin Li, Qianfeng Zhang, Zhiqian Li, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 5, pp. 2194-2209
Open Access | Times Cited: 28
Oxygen‐carrying semiconducting polymer nanoprodrugs induce sono‐pyroptosis for deep‐tissue tumor treatment
Fengshuo Wang, Yongliang Fan, Yue Liu, et al.
Exploration (2024) Vol. 4, Iss. 4
Open Access | Times Cited: 25
Fengshuo Wang, Yongliang Fan, Yue Liu, et al.
Exploration (2024) Vol. 4, Iss. 4
Open Access | Times Cited: 25
Dendritic Polymer‐Based Nanomedicines Remodel the Tumor Stroma: Improve Drug Penetration and Enhance Antitumor Immune Response
Yuxin Zhang, Zaixiang Fang, Dayi Pan, et al.
Advanced Materials (2024) Vol. 36, Iss. 25
Closed Access | Times Cited: 21
Yuxin Zhang, Zaixiang Fang, Dayi Pan, et al.
Advanced Materials (2024) Vol. 36, Iss. 25
Closed Access | Times Cited: 21
Breaking Physical Barrier of Fibrotic Breast Cancer for Photodynamic Immunotherapy by Remodeling Tumor Extracellular Matrix and Reprogramming Cancer-Associated Fibroblasts
Ziwen Qiu, Yingtao Zhong, Zhen‐Ming Lu, et al.
ACS Nano (2024) Vol. 18, Iss. 13, pp. 9713-9735
Closed Access | Times Cited: 20
Ziwen Qiu, Yingtao Zhong, Zhen‐Ming Lu, et al.
ACS Nano (2024) Vol. 18, Iss. 13, pp. 9713-9735
Closed Access | Times Cited: 20
Engineered nanoparticles for precise targeted drug delivery and enhanced therapeutic efficacy in cancer immunotherapy
Xueqiang Peng, Jianjun Fang, Chuyuan Lou, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 8, pp. 3432-3456
Open Access | Times Cited: 20
Xueqiang Peng, Jianjun Fang, Chuyuan Lou, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 8, pp. 3432-3456
Open Access | Times Cited: 20
Nanomedicines for an Enhanced Immunogenic Cell Death-Based In Situ Cancer Vaccination Response
Caiyan Zhao, Changrong Wang, Wenbo Shan, et al.
Accounts of Chemical Research (2024) Vol. 57, Iss. 6, pp. 905-918
Closed Access | Times Cited: 19
Caiyan Zhao, Changrong Wang, Wenbo Shan, et al.
Accounts of Chemical Research (2024) Vol. 57, Iss. 6, pp. 905-918
Closed Access | Times Cited: 19
Self-Adjuvanting Polyguanidine Nanovaccines for Cancer Immunotherapy
Xuanbo Zhang, Kaiyuan Wang, Zhiqiang Zhao, et al.
ACS Nano (2024) Vol. 18, Iss. 9, pp. 7136-7147
Closed Access | Times Cited: 17
Xuanbo Zhang, Kaiyuan Wang, Zhiqiang Zhao, et al.
ACS Nano (2024) Vol. 18, Iss. 9, pp. 7136-7147
Closed Access | Times Cited: 17
Inhalable metal–organic framework-mediated cuproptosis combined with PD-L1 checkpoint blockade for lung metastasis synergistic immunotherapy
Chongzheng Yan, Y Liu, Zhao Guo-zhi, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 5, pp. 2281-2297
Open Access | Times Cited: 16
Chongzheng Yan, Y Liu, Zhao Guo-zhi, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 5, pp. 2281-2297
Open Access | Times Cited: 16
An Oral Nanomedicine Elicits In Situ Vaccination Effect against Colorectal Cancer
Menghang Zu, Ya Ma, Jun Zhang, et al.
ACS Nano (2024) Vol. 18, Iss. 4, pp. 3651-3668
Open Access | Times Cited: 15
Menghang Zu, Ya Ma, Jun Zhang, et al.
ACS Nano (2024) Vol. 18, Iss. 4, pp. 3651-3668
Open Access | Times Cited: 15
Bridging the gaps in cancer photothermal therapy through the intersection of nanotechnology and cell membrane coating
Shumin Yang, Huachun Pan, Blassan P. George, et al.
Chemical Engineering Journal (2024) Vol. 484, pp. 149641-149641
Closed Access | Times Cited: 15
Shumin Yang, Huachun Pan, Blassan P. George, et al.
Chemical Engineering Journal (2024) Vol. 484, pp. 149641-149641
Closed Access | Times Cited: 15
Sequential delivery of PD-1/PD-L1 blockade peptide and IDO inhibitor for immunosuppressive microenvironment remodeling via an MMP-2 responsive dual-targeting liposome
Chuan Hu, Yujun Song, Yiwei Zhang, et al.
Acta Pharmaceutica Sinica B (2023) Vol. 13, Iss. 5, pp. 2176-2187
Open Access | Times Cited: 38
Chuan Hu, Yujun Song, Yiwei Zhang, et al.
Acta Pharmaceutica Sinica B (2023) Vol. 13, Iss. 5, pp. 2176-2187
Open Access | Times Cited: 38
Unleashing the power of porphyrin photosensitizers: Illuminating breakthroughs in photodynamic therapy
Alibasha Akbar, Syamantak Khan, Tanmay Chatterjee, et al.
Journal of Photochemistry and Photobiology B Biology (2023) Vol. 248, pp. 112796-112796
Closed Access | Times Cited: 38
Alibasha Akbar, Syamantak Khan, Tanmay Chatterjee, et al.
Journal of Photochemistry and Photobiology B Biology (2023) Vol. 248, pp. 112796-112796
Closed Access | Times Cited: 38
Enhancing drug penetration in solid tumors via nanomedicine: Evaluation models, strategies and perspectives
Xiaoding Shen, Dayi Pan, Qiyong Gong, et al.
Bioactive Materials (2023) Vol. 32, pp. 445-472
Open Access | Times Cited: 38
Xiaoding Shen, Dayi Pan, Qiyong Gong, et al.
Bioactive Materials (2023) Vol. 32, pp. 445-472
Open Access | Times Cited: 38
Polysaccharide‐Based Stimulus‐Responsive Nanomedicines for Combination Cancer Immunotherapy
Qiuxia Li, Xing Liu, Chunmei Yan, et al.
Small (2023) Vol. 19, Iss. 23
Closed Access | Times Cited: 37
Qiuxia Li, Xing Liu, Chunmei Yan, et al.
Small (2023) Vol. 19, Iss. 23
Closed Access | Times Cited: 37
Dendritic Nanomedicine with Boronate Bonds for Augmented Chemo‐Immunotherapy via Synergistic Modulation of Tumor Immune Microenvironment
Yunkun Li, Yahui Wu, Zaixiang Fang, et al.
Advanced Materials (2023) Vol. 36, Iss. 2
Closed Access | Times Cited: 37
Yunkun Li, Yahui Wu, Zaixiang Fang, et al.
Advanced Materials (2023) Vol. 36, Iss. 2
Closed Access | Times Cited: 37
Nanomedicine Combats Drug Resistance in Lung Cancer
Xiuli Zheng, Xiao-Hai Song, Guonian Zhu, et al.
Advanced Materials (2023) Vol. 36, Iss. 3
Closed Access | Times Cited: 35
Xiuli Zheng, Xiao-Hai Song, Guonian Zhu, et al.
Advanced Materials (2023) Vol. 36, Iss. 3
Closed Access | Times Cited: 35
Supramolecular nanomedicines based on host–guest interactions of cyclodextrins
Fan Tong, Yang Zhou, Yanyan Xu, et al.
Exploration (2023) Vol. 3, Iss. 4
Open Access | Times Cited: 34
Fan Tong, Yang Zhou, Yanyan Xu, et al.
Exploration (2023) Vol. 3, Iss. 4
Open Access | Times Cited: 34
In Situ Tumor Vaccine for Lymph Nodes Delivery and Cancer Therapy Based on Small Size Nanoadjuvant
Huilin Zhang, Yiwei Zhang, Haili Hu, et al.
Small (2023) Vol. 19, Iss. 33
Closed Access | Times Cited: 32
Huilin Zhang, Yiwei Zhang, Haili Hu, et al.
Small (2023) Vol. 19, Iss. 33
Closed Access | Times Cited: 32
Targeting glutamine metabolism with photodynamic immunotherapy for metastatic tumor eradication
Linping Zhao, Xiaona Rao, Rongrong Zheng, et al.
Journal of Controlled Release (2023) Vol. 357, pp. 460-471
Closed Access | Times Cited: 25
Linping Zhao, Xiaona Rao, Rongrong Zheng, et al.
Journal of Controlled Release (2023) Vol. 357, pp. 460-471
Closed Access | Times Cited: 25
Progress and challenges in the translation of cancer nanomedicines
Fan Tong, Yufan Wang, Huile Gao
Current Opinion in Biotechnology (2023) Vol. 85, pp. 103045-103045
Closed Access | Times Cited: 23
Fan Tong, Yufan Wang, Huile Gao
Current Opinion in Biotechnology (2023) Vol. 85, pp. 103045-103045
Closed Access | Times Cited: 23
Bioactive Vanadium Disulfide Nanostructure with “Dual” Antitumor Effects of Vanadate and Gas for Immune-Checkpoint Blockade-Enhanced Cancer Immunotherapy
Zifan Pei, Huali Lei, Jie Wu, et al.
ACS Nano (2023) Vol. 17, Iss. 17, pp. 17105-17121
Closed Access | Times Cited: 22
Zifan Pei, Huali Lei, Jie Wu, et al.
ACS Nano (2023) Vol. 17, Iss. 17, pp. 17105-17121
Closed Access | Times Cited: 22